DEF: BIO-key Seeks Stockholder Nod for Reverse Split to Avoid Delisting

BIO-key International, Inc. is calling a special meeting for stockholders to approve a reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.

Summary

• A special meeting of stockholders is scheduled for April 20, 2026, at 10:00 a.m. local time, to vote on a proposed amendment to the Certificate of Incorporation.
• The amendment would effect a reverse stock split of issued and outstanding common stock at a ratio between 1-for-2 and 1-for-10.
• The Board of Directors will have discretion to determine whether to proceed with the split, the exact ratio, and timing, but no later than May 6, 2026.
• The primary purpose of the reverse stock split is to assist the company in regaining compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share.
• BIO-key received a non-compliance letter on May 9, 2025, and an additional 180-day compliance period until May 4, 2026.
• As of March 13, 2026, the company's common stock traded at $0.65 per share on Nasdaq.
• The reverse stock split will affect all common stockholders uniformly, with no dilution of percentage ownership, except for immaterial adjustments due to fractional shares being rounded up.
• The number of authorized shares will remain at 170,000,000, and the par value will remain at $0.0001 per share.
• The Board of Directors unanimously recommends a vote FOR the approval of the Reverse Stock Split.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as a necessary defensive action to maintain exchange listing, but it highlights underlying issues with the company's stock performance. While preventing delisting is positive, the action itself does not improve fundamental business health, and risks of continued price decline or reduced liquidity remain.

Positives

• The proposed reverse stock split is a proactive measure to regain compliance with Nasdaq's minimum bid price requirement, preventing potential delisting.
• Maintaining Nasdaq listing can enhance the company's acceptability and marketability to the financial community and investing public.
• A higher per-share price may attract a broader range of institutional and individual investors who have policies against investing in low-priced stocks.
• The action could reduce stockholder transaction costs as a percentage of total share value for investors.
• The increase in authorized but unissued shares provides the company with flexibility for future capital needs, including public or private financings, mergers, and equity incentive awards.

Negatives

• The need for a reverse stock split indicates the company's common stock has been trading below the Nasdaq minimum bid price of $1.00 for an extended period.
• There is no assurance that the reverse stock split will increase the market price proportionally or that the price will remain above the minimum bid requirement.
• The total market capitalization of the common stock after the reverse stock split may be lower than before the split.
• A reverse stock split may result in some stockholders owning 'odd lots' (less than 100 shares), which can be more difficult or costly to sell.
• The reduced number of outstanding shares could potentially adversely affect the liquidity of the common stock.
• The increase in authorized but unissued shares, while providing flexibility, could also be construed as having an anti-takeover or dilutive effect on existing stockholders' voting power.

Risks

• No assurance of regaining or maintaining compliance with Nasdaq Listing Rule 5550(a)(2) or other listing requirements.
• The market price of common stock may not increase in proportion to the reduction in shares or remain higher than the pre-split price.
• The total market capitalization of common stock after the reverse stock split may be lower than before the split.
• Stockholders may own odd lots (less than 100 shares) which can be more difficult or costly to sell.
• The reduced number of shares outstanding could adversely affect the liquidity of the common stock.
• The increase in authorized but unissued shares could have an anti-takeover effect by diluting voting power or increasing acquisition costs.
• Future issuance of additional shares could have a dilutive effect on earnings per share, book/market value, and stockholders' percentage voting power.
• Failure to obtain stockholder approval for the reverse stock split could lead to delisting from Nasdaq.
• Inability to raise additional capital due to insufficient authorized shares if the reverse split is not approved would materially and adversely affect the business.
• Risks related to the company's history of losses and limited revenue, ability to raise additional capital, and ability to continue as a going concern.
• Risks concerning the protection of intellectual property, changes in business conditions, sales strategy, product development, and market acceptance of biometric products.
• Risks associated with security breaches, competition, expansion into foreign markets, integration of acquisitions (Swivel Secure, Portal Guard), and potential agreements with Fiber Food Systems, Inc.
• Fluctuations in foreign currency exchange rates, impact of tariffs and trade barriers, and delays in product development.
• Commercial, reputational, and regulatory risks from restatement of financial statements, non-compliance with SEC/Nasdaq reporting, and temporary loss of Form S-3 registration statement use.

Future Outlook

The company intends for the reverse stock split to help regain Nasdaq compliance and enhance the marketability of its stock. It also aims to provide flexibility for future capital needs and growth opportunities by increasing the number of authorized but unissued shares. However, there is no guarantee that the market price will increase proportionally or remain above the Nasdaq minimum, and other factors could negatively affect the stock price.

Management Comments

• "You are cordially invited to attend a special meeting of stockholders of BIO-key International, Inc. (the Company) on April 20, 2026, at 10:00 a.m., local time... The purpose of the meeting is for our stockholders to consider and approve a proposed amendment to our Certificate of Incorporation, as amended, to effect a reverse split of our issued and outstanding common stock at a ratio between 1-for-2 and 1-for-10... The Reverse Stock Split should, among other things, assist the Company in our effort to regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires that we maintain a minimum bid price of $1.00 per share." Michael W. DePasquale, Chairman and CEO.
• "Our Board of Directors believes that providing our Board of Directors with this grant of authority with respect to setting the reverse split ratio, rather than approval of a pre-determined reverse stock split ratio, will give our Board of Directors the flexibility to set the ratio in accordance with current market conditions and, therefore, allow our Board of Directors to act in the best interests of the Company and our stockholders."
• "We believe increasing the trading price of our common stock will assist in meeting the continued listing criteria of The Nasdaq Capital Market and is our best option to meet the bid price criteria to comply with the continued listing requirements. Accordingly, we believe that the Reverse Stock Split is in our stockholders best interests."
• "Our Board of Directors has determined that the reverse stock split is advisable and in the best interests of the Company and its stockholders and recommends that you vote FOR the approval of the Reverse Stock Split."

Industry Context

StockSavvy.ai notes that reverse stock splits are a common defensive maneuver for companies facing delisting from major exchanges like Nasdaq due to failing to meet minimum bid price requirements. While necessary to maintain listing, such actions do not address underlying business fundamentals. The effectiveness of a reverse split in sustaining a higher stock price is often temporary and depends heavily on the company's subsequent financial performance and market perception. Companies in the biometric technology and identity access management industries, like BIO-key, operate in a competitive and evolving landscape where sustained innovation and market penetration are crucial for long-term value creation, beyond mere stock price manipulation.

Comparison to Industry Standards

• Many small-cap technology companies, particularly those in emerging or niche sectors like biometrics, frequently face challenges in maintaining exchange listing requirements due to volatile stock performance or limited institutional interest. For example, similar situations have been observed with companies like Veru Inc. (VERU) or Aeterna Zentaris Inc. (AEZS) which have executed reverse stock splits to maintain Nasdaq compliance.
• The proposed ratio range of 1-for-2 to 1-for-10 is typical for companies seeking to elevate their stock price above the $1.00 threshold, aiming for a more 'respectable' trading range that might attract broader investor interest, including from institutional funds that have minimum price mandates (e.g., often $5.00 per share).
• The company's explicit mention of potential anti-takeover effects, while stating it's not the primary purpose, is a standard disclosure in such filings, reflecting corporate governance considerations common across publicly traded entities undergoing capital structure changes.

Corporate Governance

Stakeholder Impact

• **Shareholders:** Will experience a reduction in the number of shares held, but their percentage ownership will remain the same (subject to fractional share rounding). The goal is to increase per-share price, potentially improving marketability and reducing transaction costs, but risks of further price decline and reduced liquidity exist. The increase in authorized shares could lead to future dilution.
• **Nasdaq:** The action is intended to satisfy Nasdaq's minimum bid price requirement, maintaining the company's listing on the exchange.
• **Management/Board of Directors:** The Board gains flexibility to implement the reverse split and potentially use increased authorized shares for future corporate actions. The action helps management address a critical listing compliance issue.

Next Steps

• Stockholders to vote on the reverse stock split proposal at the Special Meeting on April 20, 2026.
• The Board of Directors will determine whether to proceed with the reverse stock split and the exact ratio (between 1-for-2 and 1-for-10) no later than May 6, 2026, if stockholder approval is obtained.
• If approved and implemented, the company will file a Certificate of Amendment with the Delaware Secretary of State to effect the reverse stock split.
• The company must notify Nasdaq of the anticipated record date of the reverse stock split prior to filing the amendment.

Key Dates

Recommendation

The proposed reverse stock split is a necessary corporate action to maintain Nasdaq listing, addressing a technical compliance issue rather than reflecting improved business fundamentals. While avoiding delisting is crucial, the split itself does not guarantee sustained price appreciation or improved operational performance. Investors should hold and monitor the company's actual financial results and strategic execution post-split, as the underlying business health will ultimately drive long-term value. The risks associated with potential further price decline and dilution from future capital raises remain pertinent.

Keywords

Reverse Stock Split, Nasdaq Compliance, Delisting Risk, Corporate Governance, Shareholder Meeting, BIO-key International, Common Stock, Equity, SEC Filing, DEF 14A